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Abstract
Background: Large-conductance, calcium-activated potassium (Maxi-K) channels are implicated
in the modulation of human uterine contractions and myometrial Ca2+ homeostasis. However, the
regulatory mechanism(s) governing the expression of Maxi-K channels with decreased calcium
sensitivity at parturition are unclear. The objectives of this study were to investigate mRNA
expression of the Maxi-K alpha subunit, and that of its splice variants, in human non-pregnant and
pregnant myometrium, prior to and after labour onset, to determine whether altered expression
of these splice variants is associated with decreased calcium sensitivity observed at labour onset.
Methods:  Myometrial biopsies were obtained at hysterectomy (non-pregnant, NP), and at
Caesarean section, at elective (pregnant not-in-labour, PNL) and intrapartum (pregnant in-labour,
PL) procedures. RNA was extracted from all biopsies and quantitative real-time RT-PCR was used
to investigate for possible differential expression of the Maxi-K alpha subunit, and that of its splice
variants, between these functionally-distinct myometrial tissue sets.
Results: RT-PCR analysis identified the presence of a 132 bp and an 87 bp spliced exon of the
Maxi-K alpha subunit in all three myometrial tissue sets. Quantitative real-time PCR indicated a
decrease in the expression of the Maxi-K alpha subunit with labour onset. While there was no
change in the proportion of Maxi-K alpha subunits expressing the 87 bp spliced exon, the
proportion of alpha subunits expressing the 132 bp spliced exon was significantly increased with
labour onset, compared to both non-pregnant and pregnant not-in-labour tissues. An increased
proportion of 132 bp exon-containing alpha subunit variants with labour onset is of interest, as
channels expressing this spliced exon have decreased calcium and voltage sensitivities.
Conclusions: Our findings suggest that decreased Maxi-K alpha subunit mRNA expression in
human myometrium at labour onset, coupled to an increased proportion of Maxi-K channels
expressing the 132 bp spliced exon, may be linked to decreased Maxi-K channel calcium and voltage
sensitivity, thereby promoting enhanced uterine activity at the time of labour.
Published: 21 September 2004
Reproductive Biology and Endocrinology 2004, 2:67 doi:10.1186/1477-7827-2-67
Received: 25 June 2004
Accepted: 21 September 2004
This article is available from: http://www.rbej.com/content/2/1/67
© 2004 Curley et al; licensee BioMed Central Ltd. 
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Reproductive Biology and Endocrinology 2004, 2:67 http://www.rbej.com/content/2/1/67
Page 2 of 9
(page number not for citation purposes)
Background
The regulatory mechanisms for uterine smooth muscle
contractility during human pregnancy and labour are
poorly understood. Such information is essential to
understanding the clinical problems associated with
human parturition and particularly preterm or premature
labour. It is clear however that the myometrium is trans-
formed from a state of relative quiescence during preg-
nancy, to one of maximal contractile activity at the time of
labour. It is also established that the state of contractility
of uterine smooth muscle is intrinsically linked to cell
membrane ion channel activity [1,2].
Potassium (K+) channels are functionally important in the
regulation of smooth muscle tone [3]. Among the diverse
family of K+ channels, large-conductance, calcium-acti-
vated K+ (Maxi-K, also known as BKCa) channels are the
predominant K+ channels in myometrium, and thus have
been implicated in the control of cellular excitability [4].
While evidence for an important role of Maxi-K channels
is not particularly strong, it is thought that they play a piv-
otal role in the modulation of uterine contractility and
myometrial calcium homeostasis. Pharmacological inhi-
bition of Maxi-K channels, by the specific channel blocker
iberiotoxin, increases contractile activity in human uter-
ine tissue [5], whereas compounds that promote Maxi-K
channel opening, such as NS1619, have a potent relaxant
effect on pregnant human myometrium [6]. Structurally,
Maxi-K channels are tetramers of a pore-forming α subu-
nit of the slo gene family, and a regulatory β subunit [7-
10]. The α subunit comprises 7 transmembrane regions
(S0-S6) and 4 intracellular hydrophobic domains (S7-
S10) [11]. The β subunit is a structurally unique, mem-
brane-spanning protein that contributes to channel gating
and pharmacology [12]. The α subunit is encoded by a
single gene. However, it achieves molecular diversity by
extensive alternative splicing of its gene transcript at sev-
eral sites [7,13-15], which generates Maxi-K channel vari-
ants. There is a substantial body of evidence indicating
that alternate splicing of the maxi-K transcript plays a
major role in regulating potassium channel conductance
[7,15]. These data include evidence for splice variation
effecting calcium and voltage sensitivity, surface expres-
sion, and sensitivity to protein phosphorylation of the
maxi-K channel [16,17]; [18]. Alternative splicing of the
maxi-K channel α subunit is considered to be a molecular
mechanism by which the channel is able to adjust and
tune its response to a variety of regulatory and conduct-
ance requirements. Further evidence of the role of alter-
nate splicing of the maxi-K transcript in altering maxi-K
protein function in myometrium is provided by the find-
ing of up-regulation of maxi-K splice variants known to
alter channel current through alterations in calcium and
voltage sensitivity in pregnant mouse myometrium [19].
What initiates alternative splicing of the α subunit tran-
script is incompletely understood, however there is evi-
dence that expression of different alternatively spliced
transcripts can be hormonally induced [20,21].
It appears that expression of different pore-forming α sub-
unit isoforms, with associated regulatory β subunits,
occurs in a tissue-specific manner, thereby providing func-
tional specificity [22]. Maxi-K channels have been identi-
fied both in human non-pregnant [23] and pregnant [24]
myometrium. For animal myometrial tissues, the data
outlining Maxi-K α subunit mRNA expression in relation
to labour are conflicting [19,25,26]. For human myo-
metrium, it has more recently been reported that protein
expression of both α and β subunits is down-regulated
with labour onset [27].
Although multiple alternatively spliced exons of the Maxi-
K α subunit have been identified [10,19,21,28], there is
no information available to date pertaining to expression
of α subunit splice variant mRNA transcripts in human
myometrium during pregnancy or at the time of labour.
Because phosphorylation sites can be introduced into the
channel protein via alternatively spliced exons [19], alter-
native splicing may represent an important control mech-
anism regulating Maxi-K channel function during
pregnancy and at labour. The aim of this study was to
investigate the expression of alternatively spliced exons of
the Maxi-K α subunit transcript in non-pregnant myo-
metrium and in pregnant myometrium, prior to and after
labour onset using quantitative real-time PCR.
Methods
Patient recruitment and tissue collection
Patient recruitment took place in the Department of
Obstetrics and Gynaecology, University College Hospital
Galway (UCHG), Ireland, between October 2001 and
August 2002. The study was approved by the Research
Ethics Committee, UCHG, and recruitment was carried
out by provision of information sheets and obtaining
written informed consent.
Biopsies of myometrium were excised from the midline of
the upper lip of the uterine incision made at caesarean sec-
tion, at elective (pregnant not-in-labour, PNL; n = 8) and
intrapartum (pregnant in-labour, PL; n = 7) procedures.
The mean age of the women was 33.3 years (range 26–42)
of whom four were primagravida and eleven were multi-
gravida. All women were delivered between 37 and 41
weeks gestation. There was no significant difference
between those undergoing elective or emergency caesar-
ean section in terms of age, parity or gestation. Women
who had received prostaglandins or oxytocin were
excluded from the study. Reasons for emergency section
included breech presentation, previous caesarean section
and abnormal foetal position. The criteria for inclusion inReproductive Biology and Endocrinology 2004, 2:67 http://www.rbej.com/content/2/1/67
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the intrapartum group were regular spontaneous uterine
contractions, effacement of the cervix, and cervical dilata-
tion >3 cm prior to caesarean section.
Samples of non-pregnant myometrium (NP; n = 7) were
excised from the body of the uterus of hysterectomy spec-
imens from pre-menopausal women. The mean age of
women undergoing hysterectomy was 42.5 years (range
34–48). Women with malignant conditions, and those
receiving exogenous hormone therapy (e.g. progesta-
gens), were excluded from the study. Immediately upon
removal, tissue samples were rinsed in sterile saline, snap
frozen in liquid nitrogen and stored at -80°C until RNA
extraction.
RNA preparation/Reverse Transcriptase-Polymerase 
Chain Reaction
RNA was isolated from frozen tissue by homogenisation
in TRIzol® Reagent (Life Technologies, Paisley, UK) [29].
RNA concentration was determined by absorbance at
A260. To eliminate any residual contaminating genomic
DNA, all RNA samples were DNase-treated with the DNA-
free™ DNA removal kit (Ambion, Huntingdon, Cam-
bridgeshire, UK), as previously described [30]. RNA con-
centration was measured again by absorbance at A260,
after removal of DNA, and adjusted to a final concentra-
tion of 500 ng/µL.
Reverse Transcriptase-Polymerase Chain Reaction (RT-
PCR) was performed to check for mRNA expression of all
potential spliced exons of the Maxi-K α subunit in non-
pregnant and pregnant myometrium, prior to and after
labour onset. Purified RNA samples were reverse tran-
scribed using oligo (dT)15 primer and 200 IU M-MLV
reverse transcriptase (Promega, Madison, WI, USA), as
previously described [30]. PCR amplification was per-
formed with 20 pmol of each specific oligonucleotide
primer pair (Table 1), and 1.25 IU Taq DNA Polymerase
(Promega, Madison, WI, USA) as previously described
[30]. Primer pairs were designed to flank predicted splice
sites, allowing spliced exon expression in these different
regions to be assessed. PCR products were separated by
electrophoresis on a 1.5% agarose gel and visualised after
ethidium bromide staining by UV illumination. Bands
identified were purified by gel extraction using Qiagen Gel
Extraction kit (Qiagen, West Sussex, UK), and sent for
sequencing (MWG-Biotech Ltd., Milton-Keynes, UK).
Splice variant-specific cDNA synthesis
Splice variant-specific cDNAs were prepared for each RNA
sample using reverse primers as shown in Table 2. 3 µg of
purified RNA (1 µg for β-actin) was reverse transcribed to
cDNA for each amplicon of interest using 500 nmol/L
specific reverse primer and 200 IU M-MLV reverse tran-
scriptase (Promega, Madison, WI, USA), as previously
described [30]. These cDNAs were stored at -20°C until
required for real-time PCR. New forward primers were
designed upstream of the spliced exon sequences, to
ensure that product size was approximately 200 bp, the
optimum product length for use with hydrolysis TaqMan
probes.
Synthesis of cDNA standards
Standards (1 × 109 to 1 × 104 cDNA copies, in 10-fold
increments) were created for each spliced exon and con-
served region amplicons, and for β-actin, to enable accu-
rate quantitation of product-specific cDNA copy numbers.
Amplicon-specific PCR products were generated by RT-
PCR (as described above) using primers shown in Table 2.
Products were purified using Qiagen PCR purification kit
(Qiagen, West Sussex, UK), quantified by absorbance at
A260, and ligated into TA cloning vector pCR® 2.1 (TA clon-
ing® kit, Invitrogen Ltd, Paisley, UK), according to manu-
facturers' instructions. Vector-ligated PCR products were
transformed into One Shot® TOP10 cells, which were
plated on Luria-Bertani (LB) agar plates containing 50 µg/
Table 1: Primer Pairs
Primer name Primer sequence (5' – 3') Primer Tm (°C)
Maxi 0F CGGAGGCAGCAGTCTTAG 58.2
Maxi 0R AAGAAAGTCACCATGGAGGAG 57.9
Maxi 1F CTCCTCCATGGTGACTTTCTT 57.9
Maxi 1R TTACAAGTGCACCGATGCTG 57.3
Maxi 2F GGAAACCGCAAGAAATAC 53.1
Maxi 2R ACCTCATGGAGAAGAGGTTG 57.3
Maxi 3F GGTCTGTCCTTCCCTACTGT 59.4
Maxi 3R CAAAGATGCAGACCACGACA 57.3
Maxi 4F GTGCCAGCAACTTTCATTAC 55.3
Maxi 4R TCAGGGTCATCATCATCGTC 57.3
Maxi 5F ACAGCATTTGCCGTCAGTG 56.7
Maxi 5R GGTCCGTCTGCTTATTTGCT 57.3
β-actin F CAACTCCATCATGAAGTGTGAC 55.8
β-actin R GCCATGCCAATCTCATCTTG 59.3Reproductive Biology and Endocrinology 2004, 2:67 http://www.rbej.com/content/2/1/67
Page 4 of 9
(page number not for citation purposes)
mL kanamycin antibiotic, and incubated overnight at
37°C. Plasmid templates containing inserts in the desired
orientation to transcribe sense RNA, as determined by col-
ony PCR, were linearized by HindIII digestion. 2 µL of
digestion products were electrophoresed on 1% agarose
gels and visualised to ensure complete plasmid
linearisation.
Sense cRNA transcripts were generated by in vitro tran-
scription using the MAXIscript™ In vitro Transcription Kit
(Ambion, Huntingdon, Cambridgeshire, UK). 1 µg of lin-
earized plasmid DNA was in vitro transcribed in a final
volume of 20 µL containing 0.5 mmol/L each of ATP,
CTP, GTP, and UTP, 2 µL 10X Transcription buffer, and 2
µL T7 Enzyme mix for 1 hr at 37°C. After transcription,
samples were treated with DNA-free™ DNA removal kit
(Ambion, Huntingdon, Cambridgeshire, UK) to remove
plasmid DNA. The supernatant, containing purified
cRNA, was pipetted onto pre-hydrated NucAway™ spin
columns (Ambion, Huntingdon, Cambridgeshire, UK) to
remove free nucleotides from the transcription reaction
and further purify the cRNA samples. These columns were
centrifuged at 1200 g for 2 min. Eluted cRNA concentra-
tion was determined by absorbance at A260. Copy
number/µL of cRNA was calculated according to the fol-
lowing formula, available from the Roche Lightcycler™
website:
Once the total amount of cRNA copies/µL had been calcu-
lated, serial dilutions of cRNA standards were produced
(from 1 × 109 cRNA copies/µL to 1 × 104 cRNA copies/µL,
in 10-fold increments) for each product-specific cRNA
molecule generated. Serially-diluted cRNA standards were
reverse transcribed in a 20 µL final volume as described
above, using transcript-specific reverse primers (Table 2),
thereby generating product-specific cDNA standards.
These cDNA standards were stored at -20°C until required
for real-time PCR.
Quantitative expression analysis using real-time PCR
Real-time PCR amplification was performed on the Light-
cycler™ instrument using the Lightcycler™ FastStart DNA
Master Hybridization Probes kit (Roche Diagnostics,
Mannheim, Germany). Hydrolysis TaqMan probes were
synthesized for each amplicon to be quantified (TIB Mol-
Biol Syntheselabour, Berlin, Germany), and are shown in
Table 2. Probes were designed with consideration taken
for the design parameters outlined by Bustin [31]. Probes
were resuspended in PCR-grade water to a working stock
concentration of 4 µmol/L, and stored in the dark at 4°C.
Prior to quantitative analysis, several titration
experiments for cDNA, probe, primer, and MgCl2 concen-
tration were performed to determine optimum reaction
conditions for amplification. The following master mix of
the reaction components was prepared to the indicated
end-concentration: 10.6 µL water, 2.4 µL MgCl2 (3 mmol/
L), 1.0 µL forward primer (0.5 µmol/L), 1.0 µL reverse
primer (0.5 µmol/L), 1.0 µL specific probe (200 nmol/L)
(see Table 2) and 2 µL Hybridization Master Mix. The
master mix (18 µL) was aliquoted into Lightcycler™ glass
capillaries (Roche Diagnostics) and 2 µL cDNA (samples
and standards) was added to respective capillaries. Capil-
laries were centrifuged at 3000 rpm for 5 s, and loaded
into the Lightcycler™ instrument.
The experimental protocol used for TaqMan probe quan-
titative analysis consisted of two stages: initial denatura-
tion (95°C for 10 mins), followed by 45 cycles of
denaturation (95°C for 0 s) and annealing/extension
(59–61°C for 50 s). The annealing temperature used in
Table 2: Amplicon-specific primer and probe sequences
Primer name Primer/Probe sequence (5' – 3') Primer/Probe Tm (°C)
Conserved F TGCACAAAGAGGTATGTCATCAC 58.9
Conserved R GTTTGCTGTGGATGGGATGGA 59.8
Conserved Probe 6F * -CCCACTCGTCGCAGTCCTCCAGCAAGAAGA XT♣ 68.9
132 bp splice F ACGCTCAAGTACCTGTGGACCGT 64.2
132 bp splice R TGTGGTTCCAGTTGAGTCACCA 60.3
132 bp Probe 6F-CTCCAGGGTGGAGTGATTGGCTGTATGTT XTCAC 71.5
87 bp splice F CATCGCAAGTGATGCCAAAGAA 58.4
87 bp splice R TCAACTGGCTCGGTCACAAGC 61.8
87 bp Probe 6F-TTGCAGCTAGATCACGCTATTCCAAAGATCCA XT 68.9
β-actin F CAACTCCATCATGAAGTGTGAC 55.8
β-actin nested R GTCAAGAAAGGGTGTAACGCA 55.4
β-actin Probe 6F-TGGCACCCAGCACAATGAAGATCAAATCA XT 70.3
* 6F = FAM reporter dye; ♣ XT = TAMRA quencher dye
61 0 23 × [] × [] copies mol concentration g L
Molecular weight g mo
//
/
µ
l l
amount copies L
[]
= [] /µReproductive Biology and Endocrinology 2004, 2:67 http://www.rbej.com/content/2/1/67
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each experiment was dependent on the melting tempera-
ture of both the primers and probe involved. Fluorescence
data were acquired at the end of each annealing/extension
cycle.
Data analysis was performed using Lightcycler™ Second
Derivatives Method software. This method automatically
determines the threshold cycle (CT) values for each indi-
vidual sample using a software algorithm, which allows
initial mRNA concentration in each sample to be accu-
rately quantified based on the standards used. Using this
method removes user influence, as well as any influence
of background fluorescence on the data. The fluorescence
display mode used was F1/F2, which is the optimal setting
for use with hydrolysis TaqMan probes. PCR products
were isolated from capillaries after each program had fin-
ished and were visualised by electrophoresis on 1.5% aga-
rose gels.
Statistical analysis
The SPSS computer software package was used for all sta-
tistical analyses (Statistical Package for the Social Sciences,
v.10, SPSS Inc., Chicago, IL, USA). Multiple group com-
parisons were made using analysis of variance (ANOVA),
which were followed by individual group comparisons
using the Tukey HSD test, where appropriate.
Results
Analysis of expression of alternatively spliced exons of the 
Maxi-K α subunit in human myometrium
RT-PCR analysis of the Maxi-K α subunit gene, using
primers designed to flank predicted splice sites, produced
a variety of bands in samples of non-pregnant (NP), preg-
nant not-in-labour (PNL) and pregnant in-labour (PL)
myometrium (data not shown). From this analysis, only
two potential alternatively spliced exon-containing PCR
products were identified in the three tissue sets assayed
(Figure 1). Sequence analysis of these bands confirmed
the presence of two alternatively spliced exons, both of
which had previously been identified in human myo-
metrium. The first was a 132 bp spliced exon located in
the S0-S1 linker region identified by Korovkina et al. [26],
and the second was an 87 bp spliced exon located in the
S8-S9 linker region identified by Wallner et al. [10]. PCR
of reverse transcriptase negative controls (RT-) and a water
control (no cDNA template) did not generate any prod-
ucts, confirming the absence of genomic DNA contamina-
tion (data not shown).
Quantitative analysis of alternatively spliced exon 
expression using real-time PCR
Quantitative analysis of alternatively spliced exon expres-
sion was performed using sequence-specific hydrolysis
TaqMan probes to analyse mRNA expression of these
exons in non-pregnant myometrium and pregnant myo-
metrium, prior to and after labour onset, as outlined. In
order to correct for random errors from sources such as
pipetting inaccuracies, separate real-time PCR reactions
Detection of alternatively spliced exon-containing RT-PCR  products Figure 1
Detection of alternatively spliced exon-containing 
RT-PCR products. Ethidium bromide stained agarose gels 
(2%) showing (A) 132 bp spliced exon-containing (437 bp) 
and exon-less (305 bp) PCR products and (B) 87 bp spliced 
exon-containing (622 bp) and exon-less (535 bp) PCR prod-
ucts, in non-pregnant (NP), pregnant not-in-labour (PNL), 
and pregnant in-labour (PL) myometrial tissues. M = 100 bp 
marker (Promega, US); M2 = 2-log ladder (New England 
Biolabs Inc., UK).
M2  NP PNL        PL 
535bp 
 622bp 
B
A
 305bp 
437bp 
M       NP    PNL     PL Reproductive Biology and Endocrinology 2004, 2:67 http://www.rbej.com/content/2/1/67
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were performed in triplicate for each amplicon involved.
Agarose gel electrophoresis, as well as sequencing
analysis, confirmed the specificity of PCR products
formed, yielding single product bands of the expected size
(data not shown).
Quantitative results for each amplicon were obtained by
determination of the threshold cycle (CT) values for each
sample, as determined mathematically by the "Second
Derivatives" method. Mean absolute cDNA copy number
values for each probed amplicon involved, in each myo-
metrial sample, were calculated and grouped per tissue set
(i.e. NP, PNL, PL), as shown in Figure 2. All data were nor-
mally distributed, as determined by Normality plots for
each group (P > 0.05). Analysis of the expression of the
housekeeping gene, β-actin, showed no significant differ-
ences between the three tissue sets assayed (P > 0.05). The
3' conserved region of the Maxi-K α subunit was analysed
as a measure of overall α subunit expression. The results
of this analysis indicated a decrease in expression of the α
subunit transcript with labour onset (Figure 2A).
Although this did not reach statistical significance (P =
0.052), the observed decrease in α subunit mRNA expres-
sion at labour is in agreement with the decrease seen in α
subunit protein levels at labour, reported recently [27].
Quantitative analysis of the expression of the 132 bp and
87 bp spliced exon transcripts indicated no significant dif-
ferences in expression, in absolute terms, between NP,
PNL, and PL tissues (P > 0.05)(Figure 2B).
The results of expression analyses for the 87 bp and 132
bp spliced exons as a proportion of the total Maxi-K α sub-
unit (i.e. the 87 bp and 132 bp variants) are demonstrated
in Figure 3. Analysis of mRNA expression of the 87 bp var-
iant indicated no significant differences between the three
tissue sets assayed (Figure 3A). Expression of this variant
mRNA accounted for only 1% of total Maxi-K α subunit
expressed. However, the proportion of Maxi-K channels
expressing the 132 bp spliced exon was significantly
increased with labour onset (PL), compared to both non-
pregnant (NP)(P < 0.05) and pregnant not-in-labour
myometrial tissues (PNL) (P < 0.01)(Figure 3B). Dupli-
cate RT and quantitative PCR analysis confirmed these
data. The increase in proportion of this 132 bp variant
could be equated to approximately 1.7 fold, from 9% to
15% of total α subunit mRNA expressed.
Discussion
In this study RT-PCR analyses were performed to identify
mRNA expression of the Maxi-K α subunit, and alterna-
tively spliced exons of this subunit, in human myo-
metrium in its non-pregnant state, and at term pregnancy,
prior to and after labour onset. This was followed by
quantitative real-time PCR, which was performed to deter-
mine the overall pattern of expression of the Maxi-K α
subunit as well as expression of alternatively spliced exons
of this subunit identified in these tissue sets.
Our findings indicate a trend towards a decrease in α sub-
unit mRNA levels with human labour onset. In order to
maintain the uterus in a quiescent state during pregnancy,
K+ channels provide a potent repolarizing current through
the efflux of K+ ions, thereby dampening cell excitability
and promoting cell relaxation [32]. Previous studies on
murine and rodent myometrium have reported conflict-
ing results for Maxi-K α subunit mRNA and protein
Maxi-K α subunit mRNA expression analysed by quantitative  real-time PCR Figure 2
Maxi-K α subunit mRNA expression analysed by 
quantitative real-time PCR. Results shown represent 
mean (± standard error of the mean, SEM) copy number val-
ues for (A) total Maxi-K α subunit (represented by the 3' 
conserved region), and β-actin, and (B) the 132 bp and 87 bp 
alternatively spliced exons of the Maxi-K α subunit. Copy 
number values were obtained based on product-specific seri-
ally-diluted cDNA standards, generated individually for each 
amplicon of interest. Tissue sets are indicated by striped col-
umns (non-pregnant, NP), black columns (pregnant not-in-
labour, PNL) and open columns (pregnant in-labour, PL).
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expression during pregnancy and with labour onset. Song
et al. [26] identified a decrease in Maxi-K α subunit pro-
tein levels in rats at term pregnancy, whereas Benkusky et
al. [19] indicated an increase in protein levels of this sub-
unit in mouse term myometrium. However, a recent
report has outlined significant down-regulation in the
protein levels of both α- and β-subunits of the Maxi-K
channel in human myometrium at labour onset, suggest-
ing that the loss of Ca2+ and voltage sensitivity is at least
partly due to decreased levels of the Maxi-K channel [27].
Our findings are in agreement with this report, with the
highest levels of mRNA expression in the PNL group, and
decreased mRNA expression of the Maxi-K α subunit with
labour onset (Figure 2). Although the decrease in mRNA
expression between PNL and PL tissues was ~50%, it was
found not to be statistically significant (P = 0.052). A
reduction in expression of the Maxi-K α subunit could
allow for enhanced myometrial contractility, as reduced α
subunit expression would permit an increase in intracellu-
lar Ca2+ levels without the activation of an opposing K+
conductance [32].
Maxi-K channels derive their molecular diversity by alter-
native splicing of their α subunit transcript at several key
sites, which generate channel variants with distinct
phenotypes [7,15,16]. Previous studies provide evidence
that alternate splicing effects calcium and voltage sensitiv-
ity of the maxi-K channel and thus channel function in
myometrium [16], surface expression [17], and sensitivity
to protein phosphorylation of the maxi-K channel [18].
Further direct evidence for the role of alternate splicing of
the maxi-K transcript in altering maxi-K protein function
in myometrium is provided by the finding of up-regula-
tion of maxi-K splice variants known to alter channel cur-
rent through alterations in calcium and voltage sensitivity
in pregnant mouse myometrium [19]. Our results from
RT-PCR analysis indicate the presence of only two spliced
exons, both of which had been identified previously, in
human myometrium. The 132 bp exon, previously identi-
fied by Korovkina et al. [28], encodes a 44 amino acid
peptide that is inserted into the first intracellular loop of
the Maxi-K α subunit, and contains four potential consen-
sus sites for post-translational modification. The 87 bp
exon, isolated by Wallner et al. [10], encodes a 29 amino
acid peptide that is introduced into the loop region
between hydrophobic regions S8 and S9 of the α subunit
protein. Protein sequence analysis of this exon using
PROSITE revealed a potential cAMP-/cGMP-protein
kinase phosphorylation site (KKeT).
Quantitative real-time PCR was used to determine
whether identified spliced exons displayed altered expres-
sion in pregnancy and/or with labour onset. The use of
hydrolysis TaqMan probes provided high reaction specifi-
city and sensitivity, and allowed for highly accurate quan-
tification of target sequences. Our results indicate that
there was no significant change in expression of the 87 bp
spliced exon, in absolute terms, in non-pregnant (NP),
pregnant not-in-labour (PNL) and pregnant in-labour
(PL) myometrium. Furthermore, analysis of the expres-
sion of this spliced exon as a proportion of the total α sub-
unit expressed (i.e. the 87 bp exon-containing α subunit
Expression of 132 bp and 87 bp variant mRNAs of the Maxi- K α subunit Figure 3
Expression of 132 bp and 87 bp variant mRNAs of the 
Maxi-K α subunit. The histograms show the mean (± 
standard error of the mean, SEM) of the ratios of spliced 
exon to total maxi-K α subunit mRNA for both (A) the 87 
bp and (B) the 132 bp variants in NP, PNL and PL tissues. 
Results indicate significantly higher expression of the 132 bp 
exon as a proportion of the total α subunit with labour 
onset, compared to non-pregnant and pregnant not-in-labour 
samples. There is no change in expression of the 87 bp vari-
ant between the three tissue sets. Tissue sets are indicated 
by striped columns (non-pregnant, NP), black columns (preg-
nant not-in-labour, PNL) and open columns (pregnant in-
labour, PL). *P < 0.05 versus PL; +P < 0.01 versus PL.
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splice variant) also showed no differences between the
three tissue sets assayed. The proportion of Maxi-K α sub-
units expressing this variant was very low, accounting for
only ~1% of Maxi-K channels expressed in the three tis-
sues sets. Little is currently known about the physiological
effects of expression of this variant of the Maxi-K channel.
However, as described above, it contains a consensus
sequence for protein kinase phosphorylation; therefore, it
may have important consequences for post-translational
modification of channel function. Also, the region into
which this exon is inserted, between hydrophobic regions
S8 and S9 of the α subunit protein, is thought to be
involved in determining the Ca2+ sensitivity of the Maxi-K
channel [16].
In contrast, while there was no significant change in the
mRNA levels of the 132 bp spliced exon in absolute terms
between the three tissue sets, there was a significant
increase (~1.7 fold) in the proportion of Maxi-K α subu-
nits expressing this exon with labour onset, compared to
both non-pregnant and pregnant not-in-labour tissues.
Messenger RNA for this 132 bp variant was expressed at
much higher levels in comparison to the 87 bp variant,
accounting for 9% of total Maxi-K channels in NP and
PNL tissues, increasing to 15% at labour onset. An
increased proportion of myometrial Maxi-K α subunits
expressing the 132 bp spliced exon with labour onset in
the human is of interest, as the presence of this exon has
been shown to decrease both the Ca2+ and voltage sensi-
tivities of the Maxi-K channel [28]. Thus, our findings may
provide an additional explanation for the observation of
decreased Ca2+ and voltage sensitivities of Maxi-K chan-
nels after labour onset [24] to reduced expression levels of
the α- and β-subunits reported recently [27]. The exact
mechanism by which the presence of this exon causes
decreased sensitivity of the Maxi-K channel is unknown. It
is possible that post-translational modifications at the
four consensus sites present in the exon, perhaps in com-
bination with conformational changes in the intracellular
loop due to its increased length, may bring about the
observed changes. Determination of the precise mecha-
nism by which the 132 bp exon causes decreased channel
sensitivity is an interesting question and is the subject of
ongoing investigations in our laboratory.
Conclusions
Following the onset of labour, the putative disabling of
the link between Ca2+  and Maxi-K channel activation
would permit Ca2+ levels in the cell to rise without the
activation of an opposing K+ conductance, hence increas-
ing the availability of Ca2+ for myometrial contraction
[30]. Our findings here suggest that, in human myo-
metrium at labour onset, in addition to decreased Maxi-K
α subunit mRNA expression, the increased proportion of
Maxi-K α subunits containing the 132 bp spliced exon
that are insensitive to Ca2+ and voltage levels, is responsi-
ble for enhanced uterine activity at the time of labour.
Whether these variants are assembled as homo- or hetero-
tetramers at the plasma membrane remains to be deter-
mined. Further investigations are required to assess factors
such as the role of β-subunit attachment and modulation
of the calcium bowl, and their input to regulation of Maxi-
K channels during human pregnancy and labour. This
study provides the first quantitative analysis of Maxi-K α
subunit mRNA expression in human myometrium, and
also highlights alternative exon splicing as a potentially
important control mechanism by which myometrial
Maxi-K channels may be modulated to suit their func-
tional requirements during these physiological processes.
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